活血化瘀类中药注射液药性研究思路探讨  

Analysis on the Drug Properties of Blood-Activating and Stasis-Removing Chinese medicine Injections

作　　者：赵珊珊[1] 贾先红[1] 毛承飞[1] 周钦荣[1] 朱红梅[1] ZHAO Shan-shan JIA Xian-bong MAO Cheng-fei ZHOU Qin-rong ZHU Hong-mei(The Affiliated Hospital of Xuzhou Medical College, Xuzhou Jiangsu 221000, China)

机构地区：[1]徐州医学院附属医院,江苏徐州221000

出　　处：《中医药导报》2017年第4期16-18,23,共4页Guiding Journal of Traditional Chinese Medicine and Pharmacy

基　　金：徐州市科技局基金资助项目(KC14SH109)

摘　　要：通过对活血化瘀类中药注射液不良反应原因的分析,指出该类药物药性研究的必要性,并从实验设计、临床及实验室研究方面对该类药物药性研究思路进行探讨。In this paper, through the analysis of the adverse reaction of Blood-Activating and Stasis- Removing Chinese medicine Injections, the author pointed out the necessity of the research for this kind of drugs, and discussed this kind of drugs, properties through the design of experiment, clinical and laboratory studies.

关 键 词：活血化瘀 中药注射液 药性 

分 类 号：R283[医药卫生—中药学]